Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

Objective. To report long-term safety and tolerability of olokizumab (OKZ) in combination with methotrexate (MTX) in subjects with active rheumatoid arthritis (RA), using pooled data from three randomised clinical trials (RCT) followed by open-label extension (OLE) study.Methods. Cumulative data fro...

Full description

Saved in:
Bibliographic Details
Main Authors: Eugen Feist, Roy M. Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S. Smolen
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-12-01
Series:Современная ревматология
Online Access:https://mrj.ima-press.net/mrj/article/view/1663
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items